Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Pacira BioSciences Stock (NASDAQ: PCRX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 1.45M |
Day Range | - - - |
52 Wk Range | 11.16 - 35.95 |
Market Cap | $658.69M |
P/E Ratio | 10.66 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 19.09% |
Days to Cover | 5.89 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Pacira BioSciences (NASDAQ:PCRX) through any online brokerage.
Other companies in Pacira BioSciences’s space includes: Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
Pacira BioSciences has a consensus price target of $39.69.
The stock price for Pacira BioSciences (NASDAQ: PCRX) is $14.28 last updated September 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Pacira BioSciences.
Pacira BioSciences’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Pacira BioSciences.
Pacira BioSciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.